Phenoxypropazine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Phenoxypropazine
Phenoxypropazine skeletal.svg
Systematic (IUPAC) name
(1-methyl-2-phenoxy-ethyl)hydrazine
Clinical data
Legal status
  • ℞ (Prescription only)
Routes of
administration		 Oral
Identifiers
CAS Number 3818-37-9
ATC code none
PubChem CID: 71467
ChemSpider 64548
UNII 8E92V52324
ChEMBL CHEMBL1909286
Chemical data
Formula C9H14N2O
Molecular mass 166.22 g/mol

Phenoxypropazine (trade name Drazine) is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was introduced as an antidepressant in 1961, but was subsequently withdrawn in 1966 due to hepatotoxicity concerns.[1][2][3][4][5]

See also

References

  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  5. ↑ Lua error in package.lua at line 80: module 'strict' not found.


<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Phenoxypropazine&oldid=721573751"